TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.

David R Spigel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.